Money · Lobbying reports · 119th Congress
H.R. 2214
12 saved lobbying reports name H.R. 2214.
12 reports
Confirmed from the official recordSenate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
Lobbying Disclosure Act reports, LDA.gov. This copy was read November 22, 2026 at 12:44 PM Eastern.
Reports that name this bill
The amount is what the report gives for the whole quarter: everything the registrant did for that client, all issues together. A linked name opens that organization’s page on this site.
| Registrant | Client | Amount for the whole quarter | Quarter | Filed | Report |
|---|---|---|---|---|---|
| EMERGENT STRATEGIES | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | $60,000.00reported as income | July to September 2026 | Open the report | |
| NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | $370,000.00reported as expenses | July to September 2026 | Open the report | |
| CVS HEALTH (AND SUBSIDIARIES) | CVS HEALTH (AND SUBSIDIARIES) | $2,040,000.00reported as expenses | July to September 2026 | Open the report | |
| EMD SERONO, INC. | EMD SERONO INC | $730,000.00reported as expenses | July to September 2026 | Open the report | |
| AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) | AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | $3,010,000.00reported as expenses | July to September 2026 | Open the report | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $7,040,000.00reported as expenses | July to September 2026 | Open the report | |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | $1,530,000.00reported as expenses | July to September 2026 | Open the report | |
| JOHNSON & JOHNSON SERVICES, INC. | JOHNSON & JOHNSON SERVICES INC | $2,220,000.00reported as expenses | July to September 2026 | Open the report | |
| ELEVANCE HEALTH, INC. | ELEVANCE HEALTH, INC. | $1,410,000.00reported as expenses | July to September 2026 | Open the report | |
| NOVARTIS | NOVARTIS | $840,000.00reported as expenses | July to September 2026 | Open the report | |
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | $3,203,049.00reported as expenses | July to September 2026 | Open the report | |
| ADVANCED POLICY CONSULTING, LLC | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | $40,000.00reported as income | July to September 2026 | Open the report |